Smithson Valley's Lilly Koenig levels up to the state track podium in her first season competing in the 3,200.

In 2024, the European Medicines Agency (EMA) approved lecanemab for the treatment of early Alzheimer's disease in patients without contraindications or risk factors for side-effects. This approval ...

Y agosto cierra la temporada con comedias, grandes como “The Naked Gun” (“¿Y dónde está el policía?”), y oscuras como “The ...

Health Canada begins a priority review of semaglutide 2.4 mg, a weekly treatment by Novo Nordisk for MASH, a liver disease ...

Intuitive secured a single port robot clearance, Resmed bought sleep testing facility Virtuox, and Precision Neuroscience ...

CVS Caremark has selected Novo Nordisk’s Wegovy as the preferred GLP-1 medication for its largest commercial template formularies, effective July 1. In March, Novo Nordisk launched NovoCare Pharmacy ...

According to CBS News, the new guidance he is requesting is to include existing drugs, vitamins, and other modalities. In other news: RFK Jr. renews the disproved claim of aborted fetal cells in ...

The ballooning obesity drug market may have a new contender after Roche struck a $5.3 billion deal to develop Danish ...

Eli Lilly on Thursday downplayed CVS Health's decision to drop the company's obesity drug Zepbound from some lists of ...

Quarterly revenue at Microsoft’s cloud-computing business jumps 21%, Eli Lilly reduces 2025 guidance, and Meta Platforms ...

Ionis Pharmaceuticals unveiled results from a survey conducted by The Harris Poll showing that 91% of surveyed adults living ...